RE: Exceptionally quiet21 Aug 2024 22:31
I love your sentiment, Steve. But how can you say 500 m is day light robbery? We are in phase 1 with no confirmed data, we are at practically the lowest rung of the ladder. There is so much further to go. The reason why some companies had done big deals is because their valuation was much higher to start with. The pharma development industry is actually full of charlatans, spivs cloaked in boffin clothes, and it is actually a very murky industry. Companies raise funds and go bust all the time. Sareum , although not obviously dodgy could very easily be a company that goes no further. People think i de ramp but i don't really. I see Sareum as continually not able to get things over the line commercially, that is my big criticism. SRA737 is case in point. They should be all over this as they should be all over update about CEO stepping down. It may seem that they are slowly slowly catching the monkey, but pretty -much every RNS they have put out over the last year or so is a twist and a reaction to something rather than a real definite plan. CEO stepping down is a really good case in point. They announce early data looks promising, the next RNS is CEO stepping down. If they though more commercially , they would have put on that RNS that he is stepping down to speed up process of licensing or something. But no they leave everyone in the dark and subsequently share price just treads water. Sareum job IS NOT to cure cancer. Sareum is early development company and as such to either get taken out or licensed so that a company with as you say deep pockets can progress it through the different phases. Dont forget we are equivalent to about lap 2 of a 10,000 km race, we are so early days